New York, NY -- (SBWIRE) -- 12/17/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Real Goods Solar, Inc (NASDAQ:RSOL), PDL BioPharma Inc (NASDAQ:PDLI)
Dynavax Technologies Corporation (NASDAQ:DVAX) the stock opened the session at $1.67 but then moved to $1.79. Dynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases. Its product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide higher and earlier protection with fewer doses than licensed vaccines.
Is DVAX a Solid Investment at These Levels? Read This Report For Details
Real Goods Solar, Inc (NASDAQ:RSOL) opened the session at $2.24 and closed the session at $2.17. Traded with volume of 3.64 million shares in the prior session and the average volume of the stock remained 2.64 million shares. Real Goods Solar, Inc. is a solar energy company serving the commercial, residential and utility customers. As of February 5, 2013, the Company had installed more than 14,500 solar power systems representing over 100 megawatts of 100% renewable energy. The Company provides its customers a complete solar solution,
Is RSOL a Solid Investment at These Levels? Read This Report For Details
PDL BioPharma Inc (NASDAQ:PDLI) opened the session at $8.08 and closed the session at $8.19. Traded with volume of 3.63 million shares in the prior session and the average volume of the stock remained 3.11 million shares. The beta of the stock remained 0.62. PDL BioPharma, Inc. (PDL) is a is a biotech company. PDL is engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.
Is PDLI a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)